Autoimmune glial fibrillar acidic protein astrocytopathy mimicking tuberculous meningitis

Hidehiro Someko1, Toshiaki Shiojiri2

  • 1General Internal Medicine, Asahi General Hospital, Asahi, Chiba, Japan someko@med.kitasato-u.ac.jp.

BMJ Case Reports
|November 18, 2022
PubMed

Insights

Autoimmune GFAP astrocytopathy can mimic tuberculous meningitis. Early identification and treatment with corticosteroids are crucial for managing this rare neurological condition.

Area of Science:

  • Neurology
  • Immunology

Background:

  • Autoimmune glial fibrillar acidic protein (GFAP) astrocytopathy is an inflammatory condition affecting the central nervous system.
  • It often presents with meningoencephalitis or myelitis, posing diagnostic challenges.

Observation:

  • A case report details a 70-year-old male with symptoms mimicking tuberculous meningitis, including lethargy, appetite loss, fever, and headache.
  • Cerebrospinal fluid analysis showed lymphocytic pleocytosis and elevated adenosine deaminase (ADA), initially suggesting tuberculosis.
  • Despite empirical anti-tuberculosis treatment, the patient's condition improved with corticosteroids.

Findings:

  • Cultures for Mycobacterium tuberculosis were negative.
  • Positive GFAP antibody testing confirmed autoimmune GFAP astrocytopathy.
  • Discontinuation of anti-tuberculosis therapy and continued corticosteroid treatment led to complete symptom resolution.

Implications:

  • Autoimmune GFAP astrocytopathy should be considered in the differential diagnosis of lymphocytic meningitis with elevated ADA.
  • This highlights the importance of considering autoimmune etiologies even with suggestive infectious markers.
  • Prompt diagnosis and appropriate immunosuppressive therapy can lead to favorable outcomes in GFAP astrocytopathy.